CAI
BEAM icon

Capital Advisors Inc’s Beam Therapeutics BEAM Stock Holding History

Capital Advisors Inc’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-108,354
Closed -$4.24M – 256
2022
Q4 		$4.24M Sell
108,354
-1,490
-1% -$66.7K 0.12% 96
2022
Q3 		$5M Buy
109,844
+1,098
+1% +$62.6K 0.15% 92
2022
Q2 		$4.21M Buy
108,746
+12,460
+13% +$495K 0.13% 94
2022
Q1 		$5.52M Buy
96,286
+5,199
+6% +$341K 0.15% 90
2021
Q4 		$7.26M Buy
91,087
+5,469
+6% +$468K 0.19% 92
2021
Q3 		$7.45M Buy
85,618
+2,651
+3% +$266K 0.22% 94
2021
Q2 		$10.7M Buy
82,967
+5,734
+7% +$457K 0.32% 93
2021
Q1 		$6.18M Buy
+77,233
New +$7.35M 0.2% 92

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Capital Advisors Inc's BEAM Position: Q1 2023 in Review

Capital Advisors Inc sold out of Beam Therapeutics (BEAM) in Q1 2023, closing a stake of 108,354 shares — an estimated $4.24M sold.

Capital Advisors Inc first reported a position in BEAM in Q1 2021 and held it in 8 quarters. The position peaked at $10.7M in Q2 2021. 206 funds tracked by Wall St. Rank hold BEAM as of Q1 2023.

  • Capital Advisors Inc reported no remaining Beam Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Capital Advisors Inc sold 108,354 Beam Therapeutics shares in Q1 2023, an estimated $4.24M.
  • Capital Advisors Inc first reported a position in Beam Therapeutics in Q1 2021 and held it in 8 quarters.
  • Capital Advisors Inc's Beam Therapeutics position peaked at $10.7M in Q2 2021.
  • 206 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2023.

Based on Capital Advisors Inc's 13F filing for Q1 2023, filed 19 Apr 2023.